Bromocriptine Protects Dopaminergic Neurons from Levodopa-Induced Toxicity by Stimulating D2Receptors
- 30 September 1999
- journal article
- Published by Elsevier BV in Experimental Neurology
- Vol. 159 (1), 98-104
- https://doi.org/10.1006/exnr.1999.7122
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-upActa Neurologica Scandinavica, 2009
- Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary culturesNeuroscience Letters, 1997
- Comparison of neurotoxicity following repeated administration of l-dopa, d-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from fisher 344 and Sprague-Dawley donorsCell Transplantation, 1997
- Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexoleJournal of Neural Transmission, 1997
- Optimized survival of hippocampal neurons in B27‐supplemented neurobasal™, a new serum‐free medium combinationJournal of Neuroscience Research, 1993
- Suppressive effect of L‐dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6‐hydroxydopamineMovement Disorders, 1993
- Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum culturesExperimental Neurology, 1991
- Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivoEuropean Journal of Pharmacology, 1991
- Multiple fluorescent ligands for dopamine receptors. II. Visualization in neural tissuesBrain Research, 1991
- 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathwayNature, 1986